Amie Vidyani, Denny Vianto, Budi W, Ulfa Kholili, Ummi Maimunah, Titong Sugihartono, Herry Purbayu, Poernomo Boedi Setiawan, Iswan A Nusi, Pangestu Adi


Recurrent esophageal varices bleeding  in  liver cirrhosis  increase  the morbidity and mortality. 50 ! 60% patients with
Esophageal Varricess (EV) will experience recurrent bleeding, 30% or one third of them will experience recurrent bleeding
one year after diagnosis of EV. Mostly recurrent bleeding will be found at 6 weeks until 6 months after the Þ rst bleeding.
Prevention of recurrent bleeding is important for survival. The aim of this research to know the risk factors of recurrent EV
bleeding in liver cirrhotic patients and the onset of recurrent bleeding after the Þ rst endoscopy. This is a  cross sectional
study. Thirty Þ ve decompensated liver cirrhosis patients that fulÞ ll the inclusion and exclusion criteria participated in this
study. After the Þ rst endoscopy, the risk factors are written, consist of sex, age, ascites, degree of varices, history of LVE/
STE the severity of liver disease, and history of consuming gastric iritating drugs. The patients followed for six months
to evaluated  the occurence of  recurrent bleeding. We used Pearson Chi-Square  test  for statistic analysis  (signiÞ cant  if
p < 0.05). SPSS 17 were used to statistic calculation. Statistic analytical showed signiÞ cant correlation (p = 0.006; OR
= 8.889; CI: 1.803 ! 43.820). On  the other hand sex, age, degree of EV, history of STE/LVE showed non signiÞ cant
correlation. The main risk factor of recurrent EV in liver cirrhosis is the severity of liver disease.


Esophageal varices, recurrent bleeding, the severity of liver disease

Full Text: PDF


  • There are currently no refbacks.